Open AccessCurrent treatment of optic nerve gliomas
Author(s) -
Marybeth K Farazdaghi,
William R. Katowitz,
Robert A. Avery
Publication year - 2019
Publication title -
current opinion in ophthalmology, with evaluated medline/current opinion in ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.371
H-Index - 86
eISSN - 1080-8132
pISSN - 1040-8738
DOI - 10.1097/icu.0000000000000587
Subject(s) - medicine , debulking , bevacizumab , optic nerve , neurofibromatosis , optic chiasm , oncology , radiation therapy , optic neuropathy , chemotherapy , pathology , ophthalmology , cancer , ovarian cancer
Optic pathway gliomas are low-grade neoplasms that affect the precortical visual pathway of children and adolescents. They can affect the optic nerve, optic chiasm, optic tracts and radiations and can either be sporadic or associated with neurofibromatosis type one. Gliomas isolated to the optic nerve (ONG) represent a subgroup of optic pathway gliomas, and their treatment remains controversial. New developments in ONG treatment have emerged in recent years, and it is necessary for clinicians to have a current understanding of available therapies.